|
시장보고서
상품코드
1593487
유방 영상 시장 규모, 점유율 및 성장 분석(기술별, 제품별, 최종 용도별, 지역별) : 산업 예측(2024-2031년)Breast Imaging Market Size, Share, Growth Analysis, By Technology (Ionizing, Non-Ionizing), By Product (Breast Imaging Systems, Software & Services), By End Use (Breast Care Centers, Diagnostic Imaging Centers), By Region - Industry Forecast 2024-2031 |
||||||
세계 유방 영상 시장 규모는 2022년 약 40억 3,000만 달러로 평가되었고, 2023년 44억 달러에서 2031년에는 84억 5,000만 달러로 성장할 것으로 예상되며, 예측 기간(2024-2031년) 동안 8.5%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.
유방 영상 진단 세계 시장은 유방암 발병률 증가와 영상 기술 발전에 힘입어 크게 성장할 것으로 예상됩니다. 유방암에 대한 인식 제고와 조기 발견을 위한 노력은 유방암 영상진단 솔루션에 대한 수요를 더욱 자극할 것으로 예상됩니다. 개인 맞춤형 의료에 대한 추세는 첨단 영상 처리의 접근성 증가와 함께 유방 영상 진단 제공업체에 새로운 기회를 제공합니다. 또한, 유방암 조사에 대한 투자 증가와 혁신적인 영상 처리 기술 개발은 이 분야의 추가 성장의 길을 열어줄 것으로 보입니다. 그러나 방사선 노출에 대한 우려, 첨단 영상 기술과 관련된 높은 비용, 검진 가이드라인의 표준화 부족 등의 문제가 시장 진출기업들에게 큰 걸림돌이 될 것으로 예상됩니다. 향후 몇 년동안 유방 영상 진단 서비스 및 기술에 대한 수요가 급증할 것으로 예상되는 가운데, 이러한 장애요인을 해결하는 것이 매우 중요할 것으로 보입니다.
Global Breast Imaging Market size was valued at around USD 4.03 billion in 2022 and is expected to rise from USD 4.40 billion in 2023 to reach a value of USD 8.45 billion by 2031, at a CAGR of 8.5% over the forecast period (2024-2031).
The global market for breast imaging is poised for significant growth, driven by the increasing incidence of breast cancer and advancements in imaging technologies. Heightened awareness of breast cancer and initiatives aimed at promoting early detection are expected to further stimulate demand for breast imaging solutions. The trend towards personalized medicine, coupled with the growing accessibility of advanced imaging procedures, presents new opportunities for breast imaging providers. Additionally, increased investments in breast cancer research and the development of innovative imaging technologies are likely to create further avenues for growth in this sector. However, the market may face challenges, including concerns about radiation exposure, the high costs associated with advanced imaging technologies, and the absence of standardized screening guidelines, which are anticipated to be significant obstacles for market players. Addressing these restraints will be crucial for companies looking to capitalize on the burgeoning demand for breast imaging services and technologies in the years to come.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Breast Imaging Market Segmental Analysis
Global Breast Imaging Market is segmented by Technology, Product, End User, and Region. Based on Technology, the market is segmented into Ionizing (Full-field Digital Mammography, Analog Mammography, Positron Emission Mammography, Electric Impedance Tomography, Cone-Beam Computed Tomography, Positron Emission Tomography & Computed Tomography, 3D Breast Tomosynthesis, and MBI/BSGI), Non-Ionizing (MRI, Thermography, Ultrasound, Optical Imaging, Automated Whole-breast Ultrasound). Based on Product, the market is segmented into Breast Imaging Systems, Software & Services, and Accessories. Based on End User, the market is segmented into Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Breast Imaging Market
The Global Breast Imaging market is significantly driven by increasing investments in medical imaging research and development, leading to the emergence of innovative breast imaging technologies and devices. These advanced solutions enhance the accuracy and efficacy of breast cancer diagnosis and treatment, making them indispensable in clinical settings. As healthcare providers increasingly adopt these superior imaging modalities to improve patient outcomes, the growing prevalence of breast cancer globally further amplifies market demand. This trend not only reflects the commitment to elevated healthcare standards but also underscores the necessity for continued advancements in breast imaging, fostering a robust and expanding market landscape in the coming years.
Restraints in the Global Breast Imaging Market
One significant market restraint for the Global Breast Imaging market is the concern surrounding radiation exposure associated with certain imaging technologies, such as mammography. This apprehension is particularly pertinent for women who are at a lower risk of developing breast cancer, as they may perceive the risks of radiation exposure as outweighing the benefits of early detection. Such fears could lead to reduced acceptance and demand for breast imaging services, potentially slowing market growth. Additionally, this concern could drive a preference for alternative imaging modalities perceived as safer, further impacting the adoption rates of conventional breast imaging technologies in the future.
Market Trends of the Global Breast Imaging Market
The Global Breast Imaging market is witnessing a significant trend towards the integration of Artificial Intelligence (AI) and Machine Learning (ML) technologies. These advancements are being increasingly adopted by breast imaging providers to automate processes, enhance diagnostic accuracy, and improve operational efficiency. AI and ML frameworks facilitate the analysis of imaging data, allowing for better detection and characterization of breast lesions. This technological evolution not only streamlines workflow but also elevates the performance of imaging modalities, thus driving growth in patient outcomes and market demand. Consequently, this trend is poised to reshape the landscape of breast imaging, making it more precise and efficient.